Investor Ideas #Potcasts,
#Cannabis News and #Stocks on the Move; Episode 418 (OTC: $CSUI) (TSX: $TGOD.TO)
(NYSE: $APHA) (TSX: $LABS.TO) (OTC: $ERBB)
Delta, Kelowna, BC, May 27, 2020
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s podcast edition of cannabis
news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/05271CSUI-TGOD-APHA-LABS-ERBB.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse
Corp. (OTC: CSUI), a research & development company licensed
under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis.
The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic
cannabis with sustainable, all-natural principles. Cannabis Suisse products are
laboratory tested to ensure the end users have access to a standardized, safe
and consistent product.
In today’s podcast we will be looking at a few
private and public company announcements.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), a leading producer of premium certified
organic cannabis, announced that it has made its first shipment of Highly
Dutch, TGOD's new mainstream brand designed for regular users. Starting
today, Highly Dutch is available in Quebec in a one-ounce format (28 grams) of
its Rotterdam OG Indica strain and will become available in additional
provinces during the weeks ahead. This launch will be followed by
additional Highly Dutch strains, sizes, and formats later this summer.
Recent studies indicate that daily users make up
26% of cannabis consumers in Canada and that their consumption represents
approximately 90% of the total volume being sold. Highly Dutch's value
proposition has been tailored specifically to meet the needs of regular
users. Research has also highlighted that 30% of daily users purchase
their cannabis in a one-ounce format, and 14% purchase it in a half-ounce
format, which guided the brand's packaging strategy. Consumers can visit highlydutch.ca for additional information on the brand.
"Our scaled production enables us to address
a larger segment of the market that prefers consuming high-quality organic
cannabis. Our research also shows that value-conscious consumers prefer buying
cannabis in larger volumes, which is why we are launching with Highly Dutch's
one-ounce format (28 grams)," commented Brian Athaide, CEO of TGOD.
"This launch is consistent with plans announced in the prospectus we filed
in April and reflects our commitment to expanding our portfolio and consumer
reach. Highly Dutch allows us to significantly broaden our consumer base and
better leverage the significant organic cultivation infrastructure we have
built while continuing to focus on the premium segment with the TGOD
brand," continued Athaide.
Quebec is the first province where TGOD deploys
its dual branding strategy; Highly Dutch's debut coincides with the launch of
four other products from TGOD's premium brand in the province – Happy Hibiscus
Maté CBD/THC (tea), Happy Hibiscus Maté THC (tea), Unite Organic dried flower,
and Harmony Organic dried flower.
Known for its award-winning glass jar, TGOD
started selling premium certified organic cannabis in the recreational market
in August 2019 with a small pilot in Ontario at the OCS. As it ramped up
its production, it gradually expanded its distribution and product
offerings. Its products are now available to medical patients nationally
and in recreational stores in every province except Prince Edward Island.
TGOD worked in partnership with Velvet Management
Inc. on its Highly Dutch distribution strategy. Velvet is the Company's
exclusive sales agent for its adult-use cannabis products in Canada.
Aphria Inc. (TSX:
APHA) (NYSE:
APHA), a leading global cannabis company, announced
that it will transfer its stock exchange listing
from the New York Stock Exchange ("NYSE") to The Nasdaq Global Select
Market ("Nasdaq"), effective Friday, June 5, 2020, after the market
close. The Company expects its common stock will begin trading as a
Nasdaq-listed security at market open on Monday, June 8, 2020 and will continue
to be listed under the ticker symbol "APHA." This transition will not
impact the Company's primary listing on the Toronto Stock Exchange (TSX: APHA).
"We are excited to have Nasdaq as our new
exchange partner. This move is a reflection of our ongoing commitment to find
cost effective ways of operating so we can continue to deliver long-term value
to shareholders," said Irwin D. Simon, Chief Executive Officer.
"Additionally, as a purpose driven Company,
we believe Nasdaq will be a good fit for Aphria, particularly given our focus
on, and the progress we have made, integrating ESG practices across our
business."
"With over 76% of Nasdaq-listed companies
reporting on at least one ESG metric, we welcome Aphria to the Nasdaq family as
they strive to integrate ESG best practices across their business and add
strategic value to all of their stakeholders," said Bob McCooey, Global
Head of Capital Markets, Nasdaq.
The last day of trading of the Company's common
stock on NYSE is expected to be Friday, June 5, 2020.
HelloMD in
collaboration with Dr. Sana-Ara Ahmed announced that it is offering support to chronic pain
patients in Alberta during COVID19. According to Statistics Canada, six million
people suffer from chronic pain across Canada. With the current mandate for
social distancing, patients across all demographics are having a difficult time
finding proper medical support.
Dr. Sana-Ara Ahmed, Specialist in Interventional
Chronic Pain and Cannabinoid Medicine, together with HelloMD are offering
virtual access care to help chronic pain patients during this difficult time.
Dr. Ahmed's knowledgeable and compassionate approach, combined with HelloMD's
turnkey set of virtual care tools, are making it easier for chronic pain
patients to receive therapeutic options, while staying safe at home.
"For me, my patients always come first and I
am always thinking about how I can best support them", said Dr. Ahmed.
"COVID19 has proved to be a challenging time, especially for my chronic
pain patients, as we cannot provide in-person consultations or care. HelloMD,
and the ease with which my team and patients have adapted to their virtual processes,
has been invaluable in helping us quickly ramp up to support new and existing
patients." She added.
Through this partnership, chronic pain patients
seeking support with medical cannabis will have access to health care
practitioners who can counsel and provide medical documents directly to Medical
Cannabis by Shoppers, easing this aspect of the health care journey for
patients.
"We offer clinics the core pieces they need
now - turnkey virtual care technology, live patient support and work flows all
uniquely attuned to medical cannabis - while enabling their practitioners
to focus on delivering patient care", said Larry Lisser, Senior Vice
President of Business Development, HelloMD. "Dr. Ahmed values offering her
patients trusted sources for fulfillment, and our integration with Medical
Cannabis by Shoppers ensures her patients get the access they seek, while
removing this administrative burden from her clinic team", Lisser
added.
"We launched Medical Cannabis by Shoppers
with one purpose: to extend trusted access to the widest variety of medical
cannabis products support to patients across Canada," said Ken Weisbrod,
Vice President of Business Development, Shoppers Drug Mart. "Offering
product fulfillment and pharmacist support to Dr. Ahmed's chronic pain patients
align with this mission", Weisbrod added.
Medical Cannabis by Shoppers is Shoppers Drug
Mart's online platform for the sale of medical cannabis. The service breaks
down existing barriers for patients by providing convenient access to a broader
range of options through a single source, alongside expert advice and counsel
from trusted healthcare professionals.
To facilitate care between Dr Ahmed and her
patients, HelloMD provides Genuvis Health with a dedicated website for its
patients to register for an online appointment. The HelloMD team assists Dr.
Ahmed's patients with onboarding, scheduling and virtually connecting with Dr
Ahmed. After the consult, and patient registration with Medical Cannabis by
Shoppers, virtual pharmacists are made available to assist with product
purchases and fulfillment.
MediPharm Labs Corp. (TSX:
LABS) (OTCQX:
MEDIF) and Argentina Gold Corporation, a
Canadian vertically integrated licensed producer, announced the formation of a supply arrangement to bring
premium cannabis-infused products to Atlantic Canada.
Under the agreement, which has an initial 2-year
term, MediPharm Labs will provide Argentia Gold-branded formulated tincture
bottles of CBD cannabis resin and Argentia Gold will provide distribution,
sales, and service to leading retailers in Newfoundland and Labrador, Prince
Edward Island, Nova Scotia and New Brunswick.
“We are committed to delivering the highest
quality products to our customers throughout Atlantic Canada and doing so in
partnership with MediPharm Labs is a virtual guarantee of success,” said Dave
Thomson, President of Argentia Gold. “As our white-label supply partner,
MediPharm Labs is able to address exactly what we need: reliable, responsive
production that meets Good Manufacturing Practice (GMP) standards backed by
some of the cannabis industry’s most knowledgeable scientists, pharmaceutical
professionals and extraction specialists. Argentia Gold’s destination is market
leadership and this agreement is an important milestone in our journey.”
Canadian consumption rates for cannabis are the
highest per capita in Atlantic Canada (up to 26.8 percent in Nova Scotia, 25.2
per cent for Newfoundland, 23.2 per cent for Prince Edward Islandi).
In comparison, the cannabis consumption rate for Ontario is up to 18.1 per centii.
“Consumers in Atlantic Canada deserve only the
very best quality cannabis-infused products and that’s exactly what they will
receive as a result of this exciting partnership,” said Pat McCutcheon, CEO of
MediPharm Labs. “Argentia Gold is deeply invested in their community,
understands the market, knows local preferences and with a trusted portfolio of
premium products will no doubt grow into one of Canada’s foremost licensed
producers. We are very proud to play a formative role in the next stage of
their development.”
American Green (OTC:
ERBB) announced
today that EZ WEED has selected and
purchased the company’s proprietary smart vending solution -- called the “AGM”
-- as their “system of choice” for EZ Weed’s new business venture
teaming up with prospective cannabis dispensaries throughout the nation.
EZ Weed is run by Managing Partner, Lauren Smee
and backed by retired NFL Linebacker-turned-venture-capitalist, Lamarr Houston.
Mr. Houston, who played professionally for the Oakland Raiders and Chicago
Bears, recently visited American Green’s AGM facility in Gastonia, NC.
According to AGM Division Head, Lindel Creed, “It was obvious to me from the
minute they both arrived at the AGM facility, that both Ms. Smee and Mr.
Houston knew exactly which machine features they required for their venture
and, by the time they left the facility, both were convinced that American
Green could provide them.”
EZ WEED expects to purchase and supply the AGM
Dispensing Vending Machines following their up-and-coming EZ Weed national
launch and have already begun securing their location agreements with some of
the top dispensaries in the US. According to Ms. Smee, “Our partnership
with American Green is vital in reaching our goal of becoming the first
national and mainstream marijuana vending machine provider and service. The
automation, humanless sales method, and intelligent vending capabilities of the
AGM will allow us to scale for high growth.”
EZ WEED was founded in January 2020. The company
came to fruition organically through a love of cannabis and Ms. Smee’s
extensive knowledge in launching startups -- with a new twist and
groundbreaking sales method in the cannabis industry. The average sales
process in a dispensary can be anywhere from 15-45 minutes. With EZ WEED, the
entire process, even as a first-time user, is on average 3 to 5 minutes.
Besides the state-of-the-art machines, EZ WEED
also provides its dispensary partners with “white glove” customer service as
well as completely customizable digital marketing for each American Green AGM
vending machine it provides. We do all the work pertaining to custom menus,
product display, machine maintenance and a dedicated account manager that
remotely keeps track of machine sales and inventory.
Once again, today’s podcast was sponsored by
Cannabis Suisse Corp. (OTC:
CSUI), a research &
development company licensed under Swiss Cannabis and tobacco regulations to
cultivate and sell cannabis. The Company's facilities for producing cannabis
are based in Zurich.
The Company grows high quality, organic
cannabis with sustainable, all-natural principles. Cannabis Suisse products are
laboratory tested to ensure the end users have access to a standardized, safe
and consistent product.
Investor ideas reminds all listeners to read our
disclaimers and disclosures on the
Investorideas.com website and this podcast is not
an endorsement to buy products or services or securities. Investors are
reminded all investment involves risk and possible loss of investment
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is
now a certified word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news, research and original financial content.
Learn about investing in stocks and sector trends with our news alerts,
articles, podcasts and videos, looking at cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s
original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move
podcast and column, Cleantech and
Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. Disclosure: CSUI is a paid monthly news and
social media client More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Contact Investorideas.com
800 665 0411
